- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03071159
An Evaluation of the FreeStyle Libre Flash Glucose Monitoring System
January 19, 2018 updated by: Jessa Hospital
A Medium-term Evaluation of the Use, the Identified Problems, the Usability and the Effect on the Metabolic Control of the FreeStyle Flash Libre Glucose Monitoring System
Medium-term (6-12 months) evaluation of the use, the identified problems, the usability and the effect on the metabolic control of the FreeStyle Flash Libre glucose monitoring system in 90 children by questionnaires and routine measurement of HbA1c values.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hasselt, Belgium, 3500
- Recruiting
- Jessa Hospital
-
Contact:
- Guy Massa, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 1 diabetes mellitis
- Being followed in the Pediatric Diabetes Unit of the Jessa Hospital
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: cases
children (4-18 years) with type 1 diabetes mellitis using the FreeStyle Flash Libre glucose monitoring system (standard care)
|
glucose monitoring system with sensors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability of the FreeStyle Flash Libre glucose monitoring system
Time Frame: 6-12 months follow up
|
Usability of the FreeStyle Flash Libre glucose monitoring system by a questionnaire
|
6-12 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Problems associated with the FreeStyle Flash Libre glucose monitoring system
Time Frame: 6-12 months follow up
|
Problems associated with the FreeStyle Flash Libre glucose monitoring system by a questionnaire
|
6-12 months follow up
|
The effect of the FreeStyle Flash Libre glucose monitoring system on the metabolic control in patients
Time Frame: 6-12 months follow up
|
The effect of the FreeStyle Flash Libre glucose monitoring system on the metabolic control in patients by measurement of the HbA1c values
|
6-12 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Guy Massa, MD, PhD, Department of Pediatric Diabetology, Jessa Ziekenhuis, Stadsomvaart 11, B3500
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 10, 2017
Primary Completion (ANTICIPATED)
March 10, 2018
Study Completion (ANTICIPATED)
March 10, 2018
Study Registration Dates
First Submitted
March 1, 2017
First Submitted That Met QC Criteria
March 1, 2017
First Posted (ACTUAL)
March 6, 2017
Study Record Updates
Last Update Posted (ACTUAL)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 19, 2018
Last Verified
February 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- JessaH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Control
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Mashhad University of Medical SciencesCompletedMetabolic ControlIran, Islamic Republic of
-
Rambam Health Care CampusUnknownMetabolic Control | Gingival ScalingIsrael
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingGlycemic ControlChina
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
American Heart AssociationCompletedGlycemic ControlUnited States
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
Clinical Trials on FreeStyle Flash Libre glucose monitoring system
-
Abbott Diabetes CareCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownDiabetes Mellitus, Type 2 | Flash Glucose MonitoringChina
-
Abbott Diabetes CareCompleted
-
Abbott Diabetes CareCompleted
-
Abbott Diabetes CareCompleted
-
Abbott Diabetes CareCompleted
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited Kingdom, Germany, Ireland
-
Abbott Diabetes CareTerminatedDiabetes MellitusUnited States
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited States
-
Abbott Diabetes CareCompletedDiabete MellitusUnited States